Sam, Author at Segra International
Segra International is a plant biotechnology company that specializes in industrial-scale cannabis plant micropropagation. The company is developing industrial-scale cannabis micropropagation laboratories to produce healthy, robust plantlets for licensed cannabis producers globally.
Segra, Cannabis Micropropagation, Cannabis Tissue Culture, Research and Development, R&D, Quality Management Systems, facilities, plant-based medicines, medicinal, Cannabis, botanical, tissue culture, specialist, Genotyping Services, Tissue Culture Production, Modular Growing Facility, Micropropagation
7
archive,author,author-sam-woolfsegra-intl-com,author-7,ajax_fade,page_not_loaded,,footer_responsive_adv,qode-child-theme-ver-1.0.0,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive
 

Author: Sam

PRESS RELEASES

VANCOUVER, British Columbia, Dec. 14th, 2018 – Segra International Corp. (“Segra” or the “Company”), a cannabis agritech company, is pleased to announce it has leased a 3,500 sq. ft. industrial building in New Westminster, British Columbia. The Company has also mutually terminated its engagement of Canaccord Genuity Corp. (“Canaccord”) as part of...

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, British Columbia, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Segra International Corp., a cannabis agritech company, has terminated the proposed acquisition by Chichi Financial Inc., citing recent market conditions as being a major factor in the decision to...